Evidence check: Mikrobiom Test in the context of Blutzucker

The claim that a microbiome test can directly guide blood sugar management is poorly supported by evidence. While gut microbiota composition is associated with glucose metabolism (e.g., via short-chain fatty acids), translating this into actionable, personalized advice from a commercial test lacks clinical validation. MyBody-X's microbiome analyses rely on population-level associations, not controlled trials with glycemic endpoints. Evidence grade: marketing/unclear. Such a test may serve as a curiosity tool but cannot replace standard diagnostics like fasting glucose, HbA1c, or OGTT. Lifestyle factors (diet, exercise, sleep) have far greater impact on blood sugar than measured bacterial profiles. Be cautious of overblown claims: without peer-reviewed validation in the specific context of blood sugar, the practical benefit remains speculative.